Testosterone Gel 1.62% + Testosterone Gel 1.62%
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hypogonadism
Conditions
Hypogonadism
Trial Timeline
May 1, 2010 → Jul 1, 2010
NCT ID
NCT01133548About Testosterone Gel 1.62% + Testosterone Gel 1.62%
Testosterone Gel 1.62% + Testosterone Gel 1.62% is a phase 1 stage product being developed by AbbVie for Hypogonadism. The current trial status is completed. This product is registered under clinical trial identifier NCT01133548. Target conditions include Hypogonadism.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01133548 | Phase 1 | Completed |
Competing Products
20 competing products in Hypogonadism